Back to results
US 2017/0281584 A1Published application
Misoprostol Dispersible Tablet
AssigneeAzanta Danmark A/S
InventorsSelvaraj SEKAR, Elumalai BASKAR, Arunachalam MALAIARASAN, Venugopal PRABHAKARAN
Life of this patent
Estimating the term…
Abstract
The present invention relates to a solid pharmaceutical formulation comprising misoprostol or a pharmaceutically acceptable salt thereof. In particular, the invention relates to a dispersible tablet comprising misoprostol or a pharmaceutically acceptable salt thereof.
Claims18
A pharmaceutical dosage form comprising misoprostol, or a pharmaceutically acceptable salt thereof, as the sole active ingredient, and at least a first disintegrant;
- wherein the dosage form is suitable for use in a treatment comprising cervical ripening or the induction of labor upon administration to a subject;
- wherein the dosage form has a content of 0.5-50 μg misoprostol, or an equivalent amount of pharmaceutically acceptable salt thereof
- wherein the dosage form is suitable for sublingual or oral administration;
- and
- wherein the dosage form disperses in 100 ml water at 25° C. within 3 minutes upon stirring, thereby providing a dispersion that passes through a sieve screen with a nominal mesh aperture of 710 μm.
2 more elements
Dependencies are inferred from the claim text.